Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ERELZI

ETANERCEPT-SZZS

Standard Dose
50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ERELZI is listed in Drugs@FDA under application 761042 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ETANERCEPT-SZZS Form and strength INJECTABLE; INJECTION - 50MG/ML Sponsor SANDOZ Submission history Latest submission status date: 2022-11-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERELZI is listed in Drugs@FDA under application 761042 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETANERCEPT-SZZS Form and strength INJECTABLE; INJECTION - 50MG/ML Sponsor SANDOZ Submission history Latest submission status date: 2022-11-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.